{{ variable.name }} : {{ variable.values[selectedVariantsIndex[variable_index]].name }}
Quantity:
Cartalax is a synthetic tripeptide (Ala-Glu-Asp or AED) developed in Russia as a tissue-specific bioregulator targeting cartilage and connective tissue.
What It Is and How It Works
• Sequence: Composed of three amino acids—alanine, glutamic acid, and aspartic acid.
• Cellular Mechanism: Unlike traditional receptor-binding drugs, Cartalax is proposed to interact directly with DNA or nuclear proteins to influence gene expression, support chondrocyte (cartilage cell) signaling, and promote extracellular matrix protein synthesis.
• Research Focus: Investigated in cellular and animal models for modulating inflammation, preserving cartilage homeostasis, and reducing cellular aging markers.
• Research Context: Sold online or through specialty vendors primarily as a "research-only" compound. Unproven peptide use should not replace proper medical evaluation, physical therapy, or evidence-based treatments for joint pain